Mayo Clinic Laboratories is committed to working with our communities as we all face the unprecedented challenges of the COVID-19 pandemic. Since early 2020, Mayo Clinic researchers and experts have provided expertise to guide the public health response, and our clinical staff has been on the front lines providing lifesaving care for patients with COVID-19.
In the wake of the CDC withdrawing its emergency use authorization request for a coronavirus PCR test, social media posts claimed the action signaled that the tests were flawed. Dr. Matthew Binnicker explains why those claims are false.
In her role as an education program manager, Heidi Zunker works to bring world-class digital education that’s rooted in Mayo Clinic expertise to thousands of people each year.
The following list includes updates posted to mayocliniclabs.com during the month of July.
In late 2019, after months of looking for a reason for his rapid loss of muscular function, David Voeltz got an answer: he had necrotizing autoimmune myopathy. Today, after nearly two years of treatment, David has a renewed lease on life and keen appreciation for the Mayo Clinic team that confirmed his diagnosis.
Topics include: COVID vaccine urgency due to delta variant, Mayo Clinic announces new phase of vaccination requirement, Mayo Clinic Q&A podcast covers the delta variant and how to stop it, and a study shows masks offer protection as COVID infections increase.
In this month’s “Hot Topic,” Julia Lehman, M.D., discusses a recent change to the direct immunofluorescence assay, specifically the addition of the IgG4 conjugate.
Today's highlights include: VA requiring Covid-19 vaccination for health care workers, CDC recommended indoor masking, possible new Covid-19 booster vaccine, the climb for cases in FL with Mayo Clinic showing no flattening curve, Mayo Clinic being ranked No. 1 for the 6th consecutive year, and if you had no side effects from the Covid-19 vaccine are you still protected?
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., review where the COVID-19 pandemic stands today and how it may change as we head into the fall.
Mayo Clinic is harnessing the extraordinary potential of digital pathology through a robust initiative that’s using the technology to enhance patient care. Mayo’s Dermatology Department is an early adopter, and clinicians, students, and patients are all reaping the benefits.
John Mills, Ph.D., explains Mayo Clinic Laboratories’ approach to MAG antibody testing. The ELISA-based assay uses higher reference ranges and human MAG antigen to detect MAG antibodies, which are associated with a rare, hard-to-treat condition known as DADS neuropathy.
Mayo Clinic Laboratories reaches patients around the globe. Alumni magazine highlights this work as it details the labs' international strategy.
This week's research roundup features a study on bipolar disorder cases that provide a new insight into underlying biology.
Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory in Mayo Clinic’s Division of Clinical Microbiology, considers the prospects for COVID-19 this fall as the traditional influenza season ramps up.
Top highlights include: Unvaccinated people at highest risk being infected by delta variant, strong immune response underlying kidney injury related to Covid, having certain type of antibodies help Covid patients avoid hospitalization, and you are you hesitant about Covid vaccine development?